Related Experiment Video
Updated: Apr 30, 2026
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
9.7K
Inhaler recognition as a marker for adherence in pediatric patients with asthma
Jenny Huang1, Mansi Kothari2, Rahul Revan1
1From the Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan.
Allergy and Asthma Proceedings
|April 29, 2026
Summary
Children unable to identify their asthma inhalers show poor medication adherence, leading to more emergency visits and steroid use. This simple bedside check can identify high-risk kids for better asthma management.
Area of Science:
- Pediatric Pulmonology
- Asthma Management
- Medication Adherence
Background:
- Poor adherence to daily asthma controller medications is a significant factor in pediatric emergency department (ED) visits and hospitalizations.
- A simple clinical tool to assess adherence in children is currently lacking.
Purpose of the Study:
- To investigate the association between a child's or caregiver's ability to recognize the prescribed daily controller inhaler and adherence to medication.
- To determine if inhaler recognition correlates with increased asthma morbidity in pediatric patients.
Main Methods:
- Retrospective chart review of 163 pediatric patients (ages 3-18) admitted for asthma exacerbation.
- Classification of patients based on their or their caregiver's ability to identify the prescribed controller inhaler.
- Comparison of clinical outcomes including ED visits, hospital admissions, systemic corticosteroid use, prescription refills, and follow-up visits between groups.
Main Results:
- Patients unable to recognize their inhaler demonstrated significantly poorer adherence, evidenced by fewer prescription refills and lower rates of specialty follow-up.
- Inability to recognize the inhaler was associated with higher rates of asthma-related ED visits and systemic corticosteroid use.
- No significant association was found with inpatient admissions, daily symptom impairment, or albuterol use frequency.
Conclusions:
- Inability to recognize a prescribed daily controller inhaler is a marker for poor adherence and increased asthma-related morbidity, including ED visits and systemic corticosteroid use.
- A simple bedside assessment of inhaler recognition can help identify high-risk pediatric asthma patients.
- This assessment may guide targeted interventions to improve adherence and enhance asthma outcomes in children.
Related Concept Videos
01:23Inhaled Medications
1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:13Asthma III: Clinical Manifestations
43
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
43
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
2.1K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K